Dapagliflozin ameliorates myocardial infarction injury through AMPKα-dependent regulation of oxidative stress and apoptosis
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82070238)
This publication has 46 references indexed in Scilit:
- Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets?Pharmacology & Therapeutics, 2013
- Role of Nrf2 in Oxidative Stress and ToxicityAnnual Review of Pharmacology and Toxicology, 2013
- Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic RatsDiabetes, 2008
- Weight Change after Myocardial Infarction—the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) ExperienceAmerican Heart Journal, 2008
- Oxidative stress and stress signaling: menace of diabetic cardiomyopathyActa Pharmacologica Sinica, 2005
- Impaired Endothelial Regulation of Ventricular Relaxation in Cardiac HypertrophyCirculation, 2001
- Free Radical Pathways in CNS InjuryJournal of Neurotrauma, 2000
- Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.Journal of Experimental Medicine, 1995
- Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.Journal of Experimental Medicine, 1995
- The Bcl-2 Oncoprotein Functions as a Pro-oxidantJournal of Biological Chemistry, 1995